Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Professor Fiona Powrie was honoured in the 2022 Queen’s Birthday Honours List, published as Her Majesty celebrates her Platinum Jubilee.

Fiona Powrie in a lab

Professor Fiona Powrie FRS, Professor of Musculoskeletal Sciences and Director of the Kennedy Institute of Rheumatology, is appointed Dame Commander of the Most Excellent Order of the British Empire (DBE), for services to Medical Science.

Professor Powrie has made major contributions to our understanding of the immune system. Her early work provided very important support for the existence of regulatory T lymphocytes, adding very strong data so that it is now universally accepted. Turning her attention to the gut she has been a leader in working out how the bacterial content interacts with the immune system. Her scientific contribution is unique and has been transformational to our understanding of how the gut bacteria and the immune system interact. She has taken this basic research in a translational direction and with her clinical colleagues is actively applying her discoveries to the management of inflammatory bowel disease. Her work has implications for bowel cancer. She has emerged as a very strong scientific leader and inspirational role model for the many young women beginning careers in biomedical science. She was appointed a Governor of the Wellcome Trust in 2018 becoming Deputy Chair in 2022.

Professor Powrie said: ‘This was an absolute surprise. So delighted and thrilled that our work to understand the regulation of the immune response in the gut has been recognised with this honour. I have been privileged to work with so many outstanding early career researchers from all over the world who worked with passion and dedication to address this challenge. This would not have been possible without the support of the University of Oxford and my colleagues in the Kennedy Institute. It is always a challenge to get the life work balance right and I am so lucky to have my husband Adrian and daughters Cara and Jessica by my side during this journey.’

Similar stories

The new Botnar strategy is announced

After a year as the Director of the Botnar Institute for Musculoskeletal Sciences, Professor Jonathan Rees announces a new structure and strategy that will further enhance research and treatment of bone, joint and musculoskeletal conditions.

New global health grant to improve outcomes for patients with hip fracture

Hip fracture patients in Low- and Middle-Income Countries (LMIC) in Asia are set to benefit from a new study that aims to bring best practice programmes to improve quality of life for patients and reduce healthcare costs.

NDORMS welcomes great-granddaughter of former Head of Department

Julia Strubell, great-granddaughter of Professor Josep Trueta, visited NDORMS to find out about his time here and to share her own work with staff and students.

Botnar researchers awarded Fellowships

Arani Vivekanantham has been awarded an NIHR Doctoral Fellowship and a Versus Arthritis Clinical Research Fellowship, and Rachel Kuo was awarded an NIHR Doctoral Research Fellowship.

Better diagnosis and treatment of autoimmune diseases moves a step closer

A study published in Nature outlines a way to find the crucial peptides (protein fragments) that drive autoimmunity, as well as the immune cells that respond to them.

New drug offers hope for people with hand osteoarthritis

A new study, published in Science Translational Medicine by researchers at the University of Oxford has identified that Talarozole, a drug that is known to increase retinoic acid, was able to prevent osteoarthritis (OA) in disease models.